Pfizer Inc. (PFE)
NYSE: PFE · Real-Time Price · USD
26.43
-0.05 (-0.19%)
Apr 29, 2026, 12:47 PM EDT - Market open
Pfizer Stock Forecast
Stock Price Forecast
The 14 analysts that cover Pfizer stock have a consensus rating of "Buy" and an average price target of $29.21, which forecasts a 10.52% increase in the stock price over the next year. The lowest target is $25 and the highest is $36.
Price Target: $29.21 (+10.52%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Pfizer stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 2 | 2 | 4 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 1 |
| Hold | 7 | 9 | 10 | 8 | 8 | 7 |
| Sell | 0 | 0 | 0 | 2 | 2 | 2 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 12 | 12 | 12 | 14 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Sell Reiterates $25 | Sell | Reiterates | $25 | -5.41% | Apr 20, 2026 |
| CICC | CICC | Buy Initiates $33 | Buy | Initiates | $33 | +24.86% | Apr 16, 2026 |
| UBS | UBS | Hold Maintains $25 → $27 | Hold | Maintains | $25 → $27 | +2.16% | Apr 13, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $27 → $28 | Hold | Maintains | $27 → $28 | +5.94% | Apr 10, 2026 |
| B of A Securities | B of A Securities | Hold Maintains $27 → $26 | Hold | Maintains | $27 → $26 | -1.63% | Apr 9, 2026 |
Financial Forecast
Revenue This Year
61.95B
from 62.58B
Decreased by -1.01%
Revenue Next Year
59.51B
from 61.95B
Decreased by -3.94%
EPS This Year
2.99
from 1.36
Increased by 119.06%
EPS Next Year
2.85
from 2.99
Decreased by -4.69%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 65.7B | 65.8B | ||||||
| Avg | 61.9B | 59.5B | ||||||
| Low | 58.6B | 54.8B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 5.0% | 6.2% | ||||||
| Avg | -1.0% | -3.9% | ||||||
| Low | -6.4% | -11.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 3.33 | 3.18 | ||||||
| Avg | 2.99 | 2.85 | ||||||
| Low | 2.74 | 2.43 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 144.0% | 6.3% | ||||||
| Avg | 119.1% | -4.7% | ||||||
| Low | 101.1% | -18.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.